About Us

Early detection saves lives.
We’re developing next-generation molecular imaging technologies that find cancer and other diseases using bio-safe magnetic nanoparticles.
Treatments are more successful and survival rates improve with early detection.
By combining high-sensitivity imaging technologies with nanoparticle technology, we aim to make the detection of diseases like cancer better and safer for patients as well as provide new methods for therapeutic intervention.
Recent Milestones
Feb 2023
Updated strategy to develop the MagSense® nanoparticle technology for use with clinical MRI systems.
Feb 2023
Dec 2022
Presented interim data from MagSense® HER2 Breast Cancer Phase I study at the San Antonio Breast Cancer Symposium showing imaging agent showed no safety findings of significance and reaches its target tissue (axillary lymph nodes) with the planned route of administration and shows unique and differentiable MR contrast pattern in nodes suspicious for tumor.
Sept 2022
Presented prostate cancer research data at the World Molecular Imaging Congress with MagSense® imaging agent showing high specificity and selectivity
Apr 2022
Sponsored Research Agreement executed with researchers at Massachusetts General Hospital focuses on MRI
Mar 2022
MagSense® HER2 Breast Cancer Phase I study interim results indicate imaging agent is well-tolerated and is reaching patient’s lymph nodes
Aug 2021
Joint Development Agreement with Global Cancer Technologies to develop nanocrystals for treatment of breast cancer
May 2021
Collaboration with Patrys (ASX:PAB) for Brain Cancer imaging
May 2021
First patient dosed in Phase I study
Mar 2021
Receive CSIRO grant to support Prostate Cancer imaging research
Mar 2020
MagSense® HER2 Breast Cancer Phase I study opens for enrolment
Oct 2020
May 2020
Research collaboration with Siemens
Jul 2019
Received FDA designation as a ”Breakthrough Device”
Why you should use our PrecisionMRX® magnetic nanoparticles for your biomedical application
We have developed a proprietary method for making magnetic nanoparticles that precisely controls for key attributes, such as size, dispersity, and magnetic properties, important in biomedical application.
There are three biomedical applications of our magnetic nanoparticles.
Research & Imaging
We sell our PrecisionMRX® nanoparticles to institutions for research purposes.
Multiple coating types available.
Whitelabeled OEM Products
We supply nanoparticles that can be used in third-party branded products across hyperthermia, human and animal vaccines, and cancer screening and treatments.
Diagnostic Imaging
MagSense® imaging agents can be developed for many types of solid tumors and can be used at multiple stages of diagnosis including primary diagnosis, staging, and prognosis of diseases.


Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.